Blood DNA Kit Market - Global Forecast 2026-2032

The blood DNA kit market is undergoing rapid transformation, shaped by fundamental shifts in technology innovation, tightening regulatory requirements, and evolving customer needs across clinical and consumer sectors. As stakeholders contend with these complexities, effective decision-making relies on a clear understanding of the interdependencies defining product development and market adoption.

Market Snapshot: Blood DNA Kit Market Growth and Trajectory

The blood DNA kit market has demonstrated robust growth, increasing from USD 997.18 million in 2025 to USD 1.06 billion in 2026, and is projected to reach USD 1.63 billion by 2032 at a CAGR of 7.36%. This expansion is underpinned by technology adoption across hospital, diagnostic, research, and direct-to-consumer applications. Market momentum reflects not only sustained clinical demand but also a widening array of product offerings targeting health risk assessment, ancestry insights, and pharmacogenomics, driving greater utilization across both established and emerging regions.

Scope & Segmentation: Blood DNA Kit Market

Comprehensive segmentation reveals the distinct factors influencing the design, positioning, and pathways to adoption for blood DNA kits:

Test Types: Ancestry, health risk assessment, paternity, and pharmacogenomics applications tailored to unique end-user requirements.
Application Areas: Ancestry tracking, forensic analysis, genetic disease screening, and personalized medicine, each with defined regulatory and operational frameworks.
Distribution Channels: Direct enrollment platforms, hospital and clinic procurement, online retail, and pharmacies accommodating various purchasing behaviors.
Analytical Techniques: Microarray, next-generation sequencing, Sanger sequencing, and PCR (including digital and real-time variants) optimizing for accuracy and workflow integration.
End Users: Diagnostic laboratories (hospital-based and independent), hospitals, research institutes, and direct-to-consumer segments with differing adoption criteria.
Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each exhibiting unique regulatory, reimbursement, and supply chain considerations.

Key Takeaways: Strategic Drivers and Considerations

Technological advances in sequencing, PCR, and sample handling are improving test reliability and reducing operational barriers, fostering specialized product tiers for clinical and consumer markets.
Evolving regulatory expectations require manufacturers to invest in robust clinical validation and transparent data management to gain both institutional and consumer trust.
Procurement behavior is shifting, with hospitals and laboratories seeking validated assays that integrate seamlessly into existing workflows, while consumer channels focus on rapid insights and data privacy.
Strategic supply chain adjustments, including diversification and regionalization, are mitigating the impact of tariff measures on reagents, instrumentation, and consumables.
Collaborations among sequencing technology providers, kit manufacturers, and clinical organizations are accelerating integrated sample-to-answer solutions and supporting market access in regulated environments.
Region-specific strategies that align products with local regulatory, clinical, and purchasing dynamics are pivotal for competitive positioning and sustained adoption.

Tariff Impact: Reconfiguring Supply and Cost Structures

Recent tariff actions have increased the baseline cost of key components, prompting manufacturers to reevaluate supply networks and pursue secondary sourcing or vertical integration. Hospitals and laboratories are responding with longer-term procurement contracts and cost-sharing arrangements, while innovation in reagent efficiency and assay design is helping offset input cost pressures. These strategies collectively reinforce supply resilience and operational flexibility in a changing global trade environment.

Methodology & Data Sources

This report integrates structured interviews with clinical and procurement leaders, detailed review of peer-reviewed technical literature, and expert validation sessions. Segmentation analysis leverages both primary and secondary sources to delineate value chain dynamics, and quality controls ensure documentation fidelity and transparency throughout the research process.

The Blood DNA Kit Market: Why This Report Matters

Enables senior decision-makers to align investment, procurement, and partnership decisions with the drivers shaping test adoption and regulatory compliance.
Clarifies how supply chain strategies, tariff impacts, and channel selection can accelerate market access and reduce operational risk.
Delivers actionable segmentation insights to support focused product roadmaps and optimize regional go-to-market approaches.

Conclusion

Decision-makers seeking growth in the blood DNA kit market must balance clinical rigor, commercial innovation, and channel strategies aligned to regional realities. This report provides the foundation for turning technical capability into market leadership as sector dynamics continue to evolve.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Blood DNA Kit Market, by Test Type

8.1. Ancestry
8.1.1. Autosomal Dna
8.1.2. Mtdna
8.1.3. Y-Dna
8.2. Health Risk Assessment
8.2.1. Disease Predisposition
8.2.2. Lifestyle Genomics
8.3. Paternity
8.4. Pharmacogenomics
8.4.1. Drug Efficacy
8.4.2. Drug Metabolism

9. Blood DNA Kit Market, by Distribution Channel

9.1. Direct Enrollment
9.1.1. Clinical Institutions
9.1.2. Corporate Wellness Programs
9.2. Hospitals & Clinics
9.2.1. Private Hospitals
9.2.2. Public Clinics
9.3. Online Retail
9.3.1. Company Websites
9.3.2. E-Commerce Platforms
9.4. Pharmacies
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies

10. Blood DNA Kit Market, by Technique

10.1. Microarray
10.2. Next Generation Sequencing
10.2.1. Targeted Sequencing
10.2.2. Whole Exome Sequencing
10.2.3. Whole Genome Sequencing
10.3. Polymerase Chain Reaction
10.3.1. Digital Pcr
10.3.2. Real-Time Pcr
10.4. Sanger Sequencing

11. Blood DNA Kit Market, by Application

11.1. Ancestry Tracking
11.1.1. Autosomal Dna
11.1.2. Mtdna
11.1.3. Y-Dna
11.2. Forensic Testing
11.2.1. Criminal Investigations
11.2.2. Paternity Investigations
11.3. Genetic Disease Screening
11.3.1. Carrier Screening
11.3.2. Newborn Screening
11.3.3. Prenatal Screening
11.4. Personalized Medicine
11.4.1. Cardiovascular Disorders
11.4.2. Neurological Disorders
11.4.3. Oncology

12. Blood DNA Kit Market, by End User

12.1. Diagnostic Laboratories
12.1.1. Hospital Based Labs
12.1.2. Independent Labs
12.2. Direct-To-Consumer
12.2.1. Single Test Purchase
12.2.2. Subscription Services
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
12.4. Research Institutes
12.4.1. Academic Institutions
12.4.2. Biotechnology Companies

13. Blood DNA Kit Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Blood DNA Kit Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Blood DNA Kit Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Blood DNA Kit Market
17. China Blood DNA Kit Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Align Technology, Inc.
18.6. Bio-Rad Laboratories, Inc.
18.7. Candid Care Co.
18.8. Carestream Dental LLC
18.9. Dental Monitoring SAS
18.10. Denteractive Solutions Inc.
18.11. Dentulu, Inc.
18.12. Macherey-Nagel GmbH & Co. KG
18.13. Merck KGaA
18.14. New England Biolabs, Inc.
18.15. PerkinElmer, Inc.
18.16. Promega Corporation
18.17. QIAGEN N.V.
18.18. Takara Bio, Inc.
18.19. Thermo Fisher Scientific, Inc.
18.20. Zymo Research Corp.

List of Figures

FIGURE 1. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BLOOD DNA KIT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BLOOD DNA KIT MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISEASE PREDISPOSITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISEASE PREDISPOSITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISEASE PREDISPOSITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD DNA KIT MARKET SIZE, BY LIFESTYLE GENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD DNA KIT MARKET SIZE, BY LIFESTYLE GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD DNA KIT MARKET SIZE, BY LIFESTYLE GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG EFFICACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG EFFICACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG EFFICACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG METABOLISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG METABOLISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG METABOLISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CLINICAL INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CLINICAL INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CLINICAL INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CORPORATE WELLNESS PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CORPORATE WELLNESS PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CORPORATE WELLNESS PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD DNA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD DNA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD DNA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BLOOD DNA KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AUTOSOMAL DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MTDNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BLOOD DNA KIT MARKET SIZE, BY Y-DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL INVESTIGATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL INVESTIGATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL INVESTIGATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY INVESTIGATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY INVESTIGATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY INVESTIGATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEWBORN SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEWBORN SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRENATAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRENATAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BLOOD DNA KIT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BLOOD DNA KIT MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BLOOD DNA KIT MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SINGLE TEST PURCHASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SINGLE TEST PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SINGLE TEST PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SUBSCRIPTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SUBSCRIPTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL BLOOD DNA KIT MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL BLOOD DNA KIT MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL BLOOD DNA KIT MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS BLOOD DNA KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 294. EUROPE BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. EUROPE BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 296. EUROPE BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 297. EUROPE BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 298. EUROPE BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 299. EUROPE BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. EUROPE BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 301. EUROPE BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 302. EUROPE BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 303. EUROPE BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 304. EUROPE BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 305. EUROPE BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 306. EUROPE BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 307. EUROPE BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 308. EUROPE BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 309. EUROPE BLOOD DNA KIT MARKET SIZE, BY FORENSIC TESTING, 2018-2032 (USD MILLION)
TABLE 310. EUROPE BLOOD DNA KIT MARKET SIZE, BY GENETIC DISEASE SCREENING, 2018-2032 (USD MILLION)
TABLE 311. EUROPE BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 312. EUROPE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. EUROPE BLOOD DNA KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 314. EUROPE BLOOD DNA KIT MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2032 (USD MILLION)
TABLE 315. EUROPE BLOOD DNA KIT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 316. EUROPE BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 318. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 319. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY ANCESTRY, 2018-2032 (USD MILLION)
TABLE 320. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 321. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY PHARMACOGENOMICS, 2018-2032 (USD MILLION)
TABLE 322. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 323. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY DIRECT ENROLLMENT, 2018-2032 (USD MILLION)
TABLE 324. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 325. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 326. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 327. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 328. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 329. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 330. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 331. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, BY ANCESTRY TRACKING, 2018-2032 (USD MILLION)
TABLE 332. MIDDLE EAST BLOOD DNA KIT MARKET SIZE, B

Companies Mentioned

Align Technology, Inc.
Bio-Rad Laboratories, Inc.
Candid Care Co.
Carestream Dental LLC
Dental Monitoring SAS
Denteractive Solutions Inc.
Dentulu, Inc.
Macherey-Nagel GmbH & Co. KG
Merck KGaA
New England Biolabs, Inc.
PerkinElmer, Inc.
Promega Corporation
QIAGEN N.V.
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Zymo Research Corp.

Table Information

Report Attribute	Details
No. of Pages	184
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.06 Billion
Forecasted Market Value ( USD ) by 2032	$ 1.63 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	16

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Blood DNA Kit Market Growth and Trajectory

Scope & Segmentation: Blood DNA Kit Market

Key Takeaways: Strategic Drivers and Considerations

Tariff Impact: Reconfiguring Supply and Cost Structures

Methodology & Data Sources

The Blood DNA Kit Market: Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

DNA Test Kits Market - Global Forecast 2026-2032

At-Home Genetic Testing Global Market Report 2025

Relationship Genetic Tests Market Report 2025

DNA Test Kits Market - Global Strategic Business Report

Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels